Aptose Biosciences Inc Balance Sheet Statement

APTO $3.75 0.0 1.1%

05/03/21

Adventurous, Small Cap, Sucker Stock

Market Cap £242.0m

Enterprise Value £172.6m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Aptose Biosciences Inc's balance sheet statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash
Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Intangibles, Net
Total Assets

Accounts Payable
Payable/Accrued
Accrued Expenses
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities

Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.